Compound ID | 171
Class: Antivirulence agent (T3SS inhibitor)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Phenoxyacetamide inhibitor of Pseudomonas aeruginosa type III secretion system |
| Institute where first reported: | Microbiotix Inc, USA |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|